Evaluating the changes brought to periodontium and bone by bone level and tissue level implants: A Randomized Control Trial

Evaluation of peri implant soft tissue and hard tissue in bone level and tissue level implants: A Randomized Control Trial - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071437

Enrollment

Registered

2024-07-26

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K081- Complete loss of teeth

Interventions

Intervention1: Placement of tissue level and bone level implants with prosthetic rehabilitation.: The placed implants shall be prosthetically rehabilitated 3 months post placement. Control Interventio

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients in the age group of 18 to 60 years 2. Patient Should be partially edentulous in posterior region of maxilla or mandible 3. Patients with good oral hygiene 4. ASA I and ASA II

Exclusion criteria

Exclusion criteria: ASA III and ASA IV, Pregnant or nursing women, Patients smoking more than 10 cigarettes a day, poor periodontal status, need for regenerative procedure and Intake of drugs that can interfere with bone healing and remodeling

Design outcomes

Primary

Measure	Time frame
Implant Stability(ISQ), Modified Sulcus Bleeding Index (Score 0-3), Peri-Implant Probing Depth, Marginal Bone Loss (mesial side and distal side), Keratinized tissue height and Gingival Biotype(Thin or Thick)Timepoint: Implant Stability at 0, 3 and 6 months: Modified Sulcus Bleeding Index 0, 3 and 6 months: Peri-Implant Probing Depth 0, 3 and 6 months: Marginal Bone Loss 0, 3 and 6 months: Keratinized tissue height 3 and 6 months and Gingival Biotype	—

Measure

Time frame

Implant Stability(ISQ), Modified Sulcus Bleeding Index (Score 0-3), Peri-Implant Probing Depth, Marginal Bone Loss (mesial side and distal side), Keratinized tissue height and Gingival Biotype(Thin or Thick)Timepoint: Implant Stability at 0, 3 and 6 months: Modified Sulcus Bleeding Index 0, 3 and 6 months: Peri-Implant Probing Depth 0, 3 and 6 months: Marginal Bone Loss 0, 3 and 6 months: Keratinized tissue height 3 and 6 months and Gingival Biotype

—

Secondary

Measure	Time frame
mplant Stability(ISQ), Modified Sulcus Bleeding Index (Score 0-3), Peri-Implant Probing Depth, Marginal Bone Loss (mesial side and distal side), Keratinized tissue height and Gingival Biotype(Thin or Thick)Timepoint: Implant Stability at 0, 3 and 6 months: Modified Sulcus Bleeding Index 0, 3 and 6 months: Peri-Implant Probing Depth 0, 3 and 6 months: Marginal Bone Loss 0, 3 and 6 months: Keratinized tissue height 3 and 6 months and Gingival Biotype	—

Measure

Time frame

mplant Stability(ISQ), Modified Sulcus Bleeding Index (Score 0-3), Peri-Implant Probing Depth, Marginal Bone Loss (mesial side and distal side), Keratinized tissue height and Gingival Biotype(Thin or Thick)Timepoint: Implant Stability at 0, 3 and 6 months: Modified Sulcus Bleeding Index 0, 3 and 6 months: Peri-Implant Probing Depth 0, 3 and 6 months: Marginal Bone Loss 0, 3 and 6 months: Keratinized tissue height 3 and 6 months and Gingival Biotype

—

Countries

India

Contacts

Public ContactAmit Kashyap M R

Rajarajeshwari Dental college and hospital

drshruthir@yahoo.co.in9880340206

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026